Skip to contentH
Haemonetics Corp
H
HAEHaemonetics Corp Q1 2012 · 10-Q
Revenue$176.48M$176.48M+3.5% vs Q1 2011 Net Income$9.79M$9.79M−42.2% vs Q1 2011 EPS Diluted$0.19$0.19−40.6% vs Q1 2011 Gross Profit$90,113,000+1.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Haemonetics Corp · CIK 313143 · Engraved from SEC EDGAR
Operating Cash Flow$553,000−98.0% Free Cash Flowderived-$7,888,000N/M Margins · derivedGross margin51.1%−1.0 pt vs Q1 2011
Operating margin7.4%−6.6 pt vs Q1 2011
Net margin5.5%−4.4 pt vs Q1 2011
ended Jun 30, 2012 · filed Aug 8, 2012 · 39 d after period end